ergotamine’s primary mechanism of action is through its binding to and activation of serotonin (5-HT) receptors, specifically the 5-HT1B and 5-HT1D subtypes. Activation of these receptors leads to vasoconstriction (narrowing of blood vessels) and inhibition of neurogenic inflammation, both contributing to relieving migraine headaches.
